Euro Roundup: EMA recommends monkeypox vaccine as multifront response advances - Regulatory Focus

The European Medicines Agency (EMA) has recommended the approval of Bavarian Nordic’s Imvanex for the prevention of monkeypox disease. EMA’s backing of the vaccine is part of a raft of measures by the agency to tackle the pathogen and mitigate its impact.

Regulatory Affairs Professionals Society (RAPS)5635 Fishers Lane, Suite 400Rockville, Maryland 20852

full article...